Ndubisi Ubaka Edebeatu

Ndubisi Ubaka Edebeatu

Auto-generated profile, based on publicly available information

Ndubisi Ubaka Edebeatu

Department of Medicine, Texila American University, Guyana

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2025 in Epidemiology and Health Data Insights
Verified
Journal Article
Open access
PDF file
AAAbdulgafar Onikoko Ahmad
Abdulgafar Onikoko Ahmad
MAModinat Aina Abayomi
Modinat Aina Abayomi
OTObinna Hilary Tony-Okpalaobi
Obinna Hilary Tony-Okpalaobi
FOFaozyat Odunayo Odetola
Faozyat Odunayo Odetola
ONOgechi Njoku
Ogechi Njoku
DADorothy Abimbola Antai
Dorothy Abimbola Antai
Antimicrobial resistance (AMR) is a growing global threat, and sub-Saharan Africa (SSA) bears a disproportionate share of this burden. This narrative review examines how deficiencies in water, sanitation, and hygiene (WASH) contribute to AMR in SSA. It draws on peer-reviewed literature, institutional reports, and regional policy documents published between 2015 and 2025. Sources were identified through databases such as PubMed, Google Scholar, and WHO/UN databases using combinations of keywords including ‘AMR’, ‘WASH’, ‘Sub-Saharan Africa’, and ‘One Health’. We survey recent literature on the regional AMR problem, the role of inadequate WASH in propagating resistant infections among humans, animals, and the environment, and the relevance of a One Health approach. Key themes include the high AMR mortality in Africa, the persistence of antibiotic residues and pathogens in poorly managed water and sanitation systems, and how poverty-related WASH gaps drive frequent infections that require antibiotics. Evidence suggests that unsafe water and sanitation facilitate the environmental circulation of resistant bacteria and genes. The One Health framework is highlighted as essential for addressing these links, since AMR crosses human, animal, and ecological domains. We conclude that improving WASH infrastructure and practices, alongside integrated AMR strategies, is critical to curb resistance in the region. Focusing on WASH under a One Health perspective can reveal overlooked pathways of AMR spread and inform targeted interventions in SSA.

4 June 2025 in Journal of Cancer and Tumor International
Verified
Journal Article
Closed access
FEFortune Itoje Ebiala
Fortune Itoje Ebiala
CUCecilia Chika Unegbu
Cecilia Chika Unegbu
POPrecious Oluwamosope Okunola
Precious Oluwamosope Okunola
OCOgochi Blessing Chukwuneke
Ogochi Blessing Chukwuneke
OOOlolade Funke Olaitan
Ololade Funke Olaitan
DODamilola Ayodele Ojo
Damilola Ayodele Ojo
Beyond the human genetic codes, epigenetics also plays a key role in regulating how genes are expressed. While mutations or genes are known to be major causes of cancer, Epigenetic alterations, including DNA methylation, histone modifications, and non-coding RNAs, play critical roles in cancer progression by altering gene expression without involving DNA sequences, yet their complexity challenges traditional analytical approaches. This review aims to elucidate how digital technologies such as artificial intelligence (AI) and machine learning (ML) uncover novel epigenetic patterns beyond DNA mutations, enhancing cancer diagnosis, prognosis, and treatment. A comprehensive literature review was conducted, analysing peer-reviewed studies from rom recent reports on PubMed, Scopus, and bioinformatics databases, focusing on AI applications in several cancers such as breast, lung, and colorectal. Findings reveal that ML algorithms, including random forests, convolutional neural networks, and autoencoders, identify epigenetic signatures some of which are methylation patterns and histone modifications with up to 60–90% of cases with high accuracy. These signatures enable early detection, as demonstrated in a pancreatic cancer study achieving 87% sensitivity using ctDNA methylation. AI-driven multi-omics integration has so far uncovered synergistic interactions, improving metastasis prediction by 15–20% in ovarian cancer. Additionally, AI facilitates personalized epigenetic therapies, with models predicting response to histone deacetylase inhibitors in multiple myeloma with 90% accuracy. However, there are limitations to overcome. Some of which are data heterogeneity and model interpretability which exists in the nuances of machine systems. Ongoing research are currently exploring federated learning and explainable AI to address imminent challenges which would enhance generalizability and clinical trust. Future directions include single-cell epigenomics and AI applications in rare cancers to democratize precision medicine. Collaborative efforts among data scientists, clinicians, and biologists are essential to translate these insights into transformative cancer care.

31 October 2026 in Infectious
Verified
Journal Article
Open access
NENdubisi Ubaka Edebeatu
Ndubisi Ubaka Edebeatu
Despite major advances in HIV testing, antiretroviral therapy (ART), pre-exposure prophylaxis (PrEP), and surveillance, ongoing transmission and persistent gaps across the HIV care continuum remain important public-health challenges. Most surveillance systems, however, remain predominantly retrospective: they describe diagnoses, transmission clusters, care disengagement, and viral non-suppression after these patterns have already emerged. Artificial intelligence (AI) and predictive analytics offer the possibility of shifting surveillance toward earlier identification of emerging risks, but improved predictive performance does not necessarily translate into effective prevention. This critical narrative review examines the evolving role of AI in HIV surveillance, integrating evidence across routine surveillance and care-continuum data, molecular and genomic surveillance, clinical and electronic health records, and behavioral, social, geographic, and mobility information. Particular attention is given to data latency, prediction horizon and lead time, concept drift, transportability, multimodal integration, the prediction-to-response gap, and ethical and equity concerns. The review argues that the central challenge is no longer simply whether HIV-related outcomes can be predicted, but whether predictions provide sufficiently early, validated, interpretable, equitable, and actionable intelligence to change public-health decisions and outcomes. To address this gap, I propose an AI-enabled anticipatory HIV surveillance framework organized around BSERVE → INTEGRATE → DETECT → PREDICT → VALIDATE → PRIORITIZE → RESPOND → EVALUATE → LEARN. Future progress should therefore be evaluated by the ability of predictive surveillance to generate meaningful lead time and enable interventions that improve HIV prevention and care.

3 February 2026 in Journal of Contemporary Studies in Epidemiology and Public Health
Verified
Journal Article
Open access
VNVivian Ukamaka Nwokedi
Vivian Ukamaka Nwokedi
MAModinat Aina Abayomi
Modinat Aina Abayomi
AAAhmad Onikoko Abdulgafar
Ahmad Onikoko Abdulgafar
NENdubisi Ubaka Edebeatu
Ndubisi Ubaka Edebeatu
ONOgechi Njoku
Ogechi Njoku
Vulnerable populations all around the world, especially those in low-resource settings, continue to suffer the consequences of neglected tropical diseases (NTDs). Methods of diagnosis that are considered traditional are frequently insufficient when it comes to the successful identification and management of NTDs related issues. This study examines how novel diagnostic technologies improve diagnosis accuracy, accessibility, and cost-effectiveness for NTD management. In carrying out this review, a scoping review was adopted using PubMed and grey literature sources. The search yielded 336 articles, of which 23 were selected through title and abstract screening. After reviewing the complete text, 9 studies met the eligibility criteria for inclusion. New diagnostic techniques like rK39 and rK28 NTDs, molecular diagnostics, and point-of-care testing showed better sensitivity, specificity, and accessibility than older methods. Studies also showed that they might be used in the field to improve disease surveillance and treatment uptake, especially for visceral leishmaniasis, schistosomiasis, and lymphatic filariasis. The use of innovative diagnostic technologies is very helpful for controlling NTDs because they make it easier to get accurate diagnoses in places where resources are limited. Subsequent study must concentrate on the expansion of these technologies, the resolution of infrastructural constraints, and the investigation of their contribution to global efforts in the eradication of NTDs.